{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T15:31:18Z","timestamp":1785598278665,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite stage IV categorization, survival outcomes for breast cancer patients who experience contralateral axillary lymph node metastasis (CAM) remain uncertain. This study aimed to investigate the clinical outcomes for patients with metachronous CAM to provide insights into its prognosis and treatment recommendations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study retrospectively reviewed medical records of patients who underwent curative surgery for breast cancer and experienced CAM as the first site of distant metastasis (DM) during the follow-up period between January 2001 and April 2023. Survival outcomes of the CAM patients were compared with those of breast cancer patients with other DM via propensity score-matching (PSM).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study identified 40 breast cancer patients with metachronous CAM. The estimated 5-year overall survival (OS) was 39.6%, and the progression-free survival was 39.4%. The patients with CAM exhibited marginally better OS than the patients with DM (<jats:italic>p<\/jats:italic> = 0.071), but survival similar to that of the patients with isolated supraclavicular node recurrence (SCN) (<jats:italic>p<\/jats:italic> = 0.509). Moreover, matching of CAM with DM using two PSM models showed a consistently insignificant survival difference (hazard ratio [HR], 1.47; <jats:italic>p<\/jats:italic> = 0.124 vs. HR, 1.19; <jats:italic>p<\/jats:italic> = 0.542). Ipsilateral breast tumor recurrences (IBTRs) were experienced by 12 patients before or concurrently with the CAM. These patients exhibited significantly better survival than the remaining patients (HR, 0.28; <jats:italic>p<\/jats:italic> = 0.024).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The breast cancer patients with CAM showed survival similar to that for the patients with DM, supporting the current stage IV classification of the CAM. However, CAM associated with IBTR exhibited superior survival outcomes, suggesting that this subset of CAM may benefit from treatments with curative intent.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-024-15370-1","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T14:02:34Z","timestamp":1714658554000},"page":"5189-5196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Survival After Contralateral Axillary Metastasis in Breast Cancer"],"prefix":"10.1245","volume":"31","author":[{"given":"Ji-Jung","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Ho","family":"Cheun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunhye","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikbeom","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyoung","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwajeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Byoel","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonshik","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong-Gon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"15370_CR1","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ejso.2011.01.024","volume":"37","author":"B Morcos","year":"2011","unstructured":"Morcos B, Jaradat I, El-Ghanem M. Characteristics of and therapeutic options for contralateral axillary lymph node metastasis in breast cancer. Eur J Surg Oncol. 2011;37:418\u201321.","journal-title":"Eur J Surg Oncol"},{"key":"15370_CR2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1177\/1778.19258","volume":"100","author":"W Wang","year":"2014","unstructured":"Wang W, Yuan P, Wang J, Ma F, Zhang P, Li Q, Xu B. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma. Tumori J. 2014;100:600\u20134.","journal-title":"Tumori J"},{"key":"15370_CR3","doi-asserted-by":"publisher","first-page":"869397","DOI":"10.3389\/fonc.2022.869397","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang L, Wang XZ, Li C, Yu Q, Liu Z, Yu ZY. Contralateral axillary lymph node metastasis of breast cancer: retrospective analysis and literature review. Front Oncol. 2022;12:869397.","journal-title":"Front Oncol."},{"key":"15370_CR4","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ejso.2015.05.015","volume":"41","author":"M Moossdorff","year":"2015","unstructured":"Moossdorff M, Vugts G, Maaskant-Braat AJ, Strobbe LJ, Voogd AC, Smidt ML, Nieuwenhuijzen GA. Contralateral lymph node recurrence in breast cancer: regional event rather than distant metastatic disease. A systematic review of the literature. Eur J Surg Oncol. 2015;41:1128\u201336.","journal-title":"Eur J Surg Oncol"},{"key":"15370_CR5","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1245\/s10434-020-08605-4","volume":"27","author":"F Magnoni","year":"2020","unstructured":"Magnoni F, Colleoni M, Mattar D, et al. Contralateral axillary lymph node metastases from breast carcinoma: is it time to review TNM cancer staging? Ann Surg Oncol. 2020;27:4488\u201399.","journal-title":"Ann Surg Oncol"},{"key":"15370_CR6","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1245\/s10434-022-12134-7","volume":"29","author":"SB Coopey","year":"2022","unstructured":"Coopey SB. Supraclavicular and contralateral axillary lymph node involvement in breast cancer patients. Ann Surg Oncol. 2022;29:6100\u20135.","journal-title":"Ann Surg Oncol"},{"key":"15370_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1200\/JCO.1987.5.1.55","volume":"5","author":"GM Clark","year":"1987","unstructured":"Clark GM, Sledge GW Jr, Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1015 breast cancer patients. J Clin Oncol. 1987;5:55\u201361.","journal-title":"J Clin Oncol"},{"key":"15370_CR8","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1200\/JCO.1998.16.7.2401","volume":"16","author":"N Yamamoto","year":"1998","unstructured":"Yamamoto N, Watanabe T, Katsumata N, et al. Construction and validation of a practical prognostic index for patients with metastatic breast cancer. J Clin Oncol. 1998;16:2401\u20138.","journal-title":"J Clin Oncol"},{"key":"15370_CR9","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1200\/CCI.21.00020","volume":"5","author":"CH Barcenas","year":"2021","unstructured":"Barcenas CH, Song J, Murthy RK, et al. Prognostic model for de novo and recurrent metastatic breast cancer. JCO Clin Cancer Inform. 2021;5:789\u2013804.","journal-title":"JCO Clin Cancer Inform"},{"key":"15370_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, et al. The eighth-edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67:93\u20139.","journal-title":"CA Cancer J Clin"},{"key":"15370_CR11","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1245\/s10434-009-0334-7","volume":"16","author":"SY Jung","year":"2009","unstructured":"Jung SY, Han W, Lee JW, et al. Ki-67 expression gives additional prognostic information on St. Gallen 2007 and adjuvant! Online risk categories in early breast cancer. Ann Surg Oncol. 2009;16:1112\u201321.","journal-title":"Ann Surg Oncol"},{"key":"15370_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10549-013-2711-y","volume":"141","author":"DJ Lobbezoo","year":"2013","unstructured":"Lobbezoo DJ, van Kampen RJ, Voogd AC, et al. Prognosis of metastatic breast cancer subtypes: the hormone receptor\/HER2-positive subtype is associated with the most favorable outcome. Breast Cancer Res Treat. 2013;141:507\u201314.","journal-title":"Breast Cancer Res Treat"},{"key":"15370_CR13","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/bjc.2015.127","volume":"112","author":"DJ Lobbezoo","year":"2015","unstructured":"Lobbezoo DJ, van Kampen RJ, Voogd AC, et al. Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer? Br J Cancer. 2015;112:1445\u201351.","journal-title":"Br J Cancer"},{"key":"15370_CR14","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28:3271\u20137.","journal-title":"J Clin Oncol"},{"key":"15370_CR15","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1093\/annonc\/mdn424","volume":"19","author":"R Largillier","year":"2008","unstructured":"Largillier R, Ferrero JM, Doyen J, et al. Prognostic factors in 1038 women with metastatic breast cancer. Ann Oncol. 2008;19:2012\u20139.","journal-title":"Ann Oncol"},{"key":"15370_CR16","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/annonc\/mdw036","volume":"27","author":"ES Lee","year":"2016","unstructured":"Lee ES, Jung SY, Kim JY, et al. Identifying the potential long-term survivors among breast cancer patients with distant metastasis. Ann Oncol. 2016;27:828\u201333.","journal-title":"Ann Oncol"},{"key":"15370_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1524-4741.2007.00390.x","volume":"13","author":"TL Huston","year":"2007","unstructured":"Huston TL, Pressman PI, Moore A, et al. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma. Breast J. 2007;13:158\u201364.","journal-title":"Breast J"},{"key":"15370_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.clbc.2017.10.019","volume":"18","author":"R Chkheidze","year":"2018","unstructured":"Chkheidze R, Sanders MAG, Haley B, Leitch AM, Sahoo S. Isolated contralateral axillary lymph node involvement in breast cancer represents a locally advanced disease not distant metastases. Clin Breast Cancer. 2018;18:298\u2013304.","journal-title":"Clin Breast Cancer"},{"key":"15370_CR19","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3390\/jcm9041192","volume":"9","author":"JM Ryu","year":"2020","unstructured":"Ryu JM, Chae BJ, Lee JE, Yu J, Nam SJ, Kim SW, Lee SK. Aberrant lymphatic drainage in the contralateral axilla in patients with isolated ipsilateral breast tumor recurrence. J Clin Med. 2020;9:1192. https:\/\/doi.org\/10.3390\/jcm9041192","journal-title":"J Clin Med"},{"key":"15370_CR20","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1245\/s10434-014-4338-6","volume":"22","author":"CC Uth","year":"2015","unstructured":"Uth CC, Christensen MH, Oldenbourg MH, et al. Sentinel lymph node dissection in locally recurrent breast cancer. Ann Surg Oncol. 2015;22:2526\u201331.","journal-title":"Ann Surg Oncol"},{"key":"15370_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.breast.2014.03.007","volume":"23","author":"O Cordoba","year":"2014","unstructured":"Cordoba O, Perez-Ceresuela F, Espinosa-Bravo M, et al. Detection of sentinel lymph node in breast cancer recurrence may change adjuvant treatment decision in patients with breast cancer recurrence and previous axillary surgery. Breast. 2014;23:460\u20135.","journal-title":"Breast"},{"key":"15370_CR22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10549-015-3571-4","volume":"153","author":"G Vugts","year":"2015","unstructured":"Vugts G, Maaskant-Braat AJ, Voogd AC, et al. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer. Breast Cancer Res Treat. 2015;153:549\u201356.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15370-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15370-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15370-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T21:03:47Z","timestamp":1720645427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15370-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["15370"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15370-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"13 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant\u00a0conflict of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}